Abstract
Introduction: As of 2017, the World Health Organization (WHO) classification included diffuse large B-cell lymphoma, Epstein-Barr virus (EBV) positive, not otherwise specified (LDGCBEBV+) as an entity in the group of aggressive non-Hodgkin lymphomas. EBV is an important virus in the etiopathogenesis of lymphoproliferative diseases, such as the EBV-associated mucocutaneous ulcer, and of ly…